Akebia Therapeutics, Inc. (AKBA): Bullish PT Set

AKBA – Mizuho Securities sets PT at $24. Stock price at the time of this analyst call was $13.85.


Update: As of Sep. 19, 2018, this bullish analyst call has returned -44.93%.


Key Facts Surrounding This News Item


  • AKBA had a POWR Rating of C (Neutral) coming into today.
  • AKBA was -2.73% below its 10-Day Moving Average coming into today.
  • AKBA was -1.61% below its 20-Day Moving Average coming into today.
  • AKBA was -4.50% below its 50-Day Moving Average coming into today.
  • AKBA was -9.10% below its 100-Day Moving Average coming into today.
  • AKBA was -8.26% below its 200-Day Moving Average coming into today.
  • AKBA had returned -4.51% year-to-date leading up to today’s news, versus a +2.26% return from the benchmark S&P 500 during the same period.

More Info About Akebia Therapeutics, Inc. (AKBA)


Akebia Therapeutics focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. The company was founded in 2007 and is based in Cambridge, Massachusetts. View our full AKBA ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

AKBA at a Glance

AKBA Current POWR Rating™
Overall POWR Rating™
AKBA Current Price $7.82 0.51%
More AKBA Ratings, Data, and News

AKBA Price Reaction

The day of this event (Mar. 7, 2018)
AKBA Closing Price$13.85 2.46%
AKBA Volume480,900
4.36% from avg
Leading up to this event
AKBA 1-mo return1.11%
After this event
AKBA 1-day return4.41%
AKBA 3-day return5.03%
AKBA 5-day return15.82%

AKBA Price Chart



More Akebia Therapeutics, Inc. (AKBA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All AKBA News
Page generated in 1.0969 seconds.